Bullboard - Stock Discussion Forum Defence Therapeutics Inc C.DTC

Alternate Symbol(s): DTCFF

Healthcare Biotechnology

Defence Therapeutics Inc. is a clinical-stage biotechnology company. The Company is engaged in developing and engineering the radio-immuno-conjugate and antibody drug conjugates (ADC) products using its proprietary platform in addition to immune-oncology vaccines. Its principal business activity is the development of a biological drug enhancer platform that improves the efficacy and safety of a... see more

Add To Watchlist

CSE:DTC - Post Discussion

Defence Therapeutics Inc > Exercise of Warrants for Gross Proceeds of Over $2.3 M C.DTC

View:

Post by Betteryear2 on May 26, 2023 5:34pm

Exercise of Warrants for Gross Proceeds of Over $2.3 M C.DTC

Vancouver, British Columbia--(Newsfile Corp. - May 26, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce that, in addition to the previously announced proceeds of $5,494,375 on March 17, 2023, it has received additional proceeds in the aggregate amount of $2,308,625 from the exercise of warrants, pursuant to an early warrant exercise program (the "Early Warrant Exercise Program").

Defence Announces Additional and Final Exercises of Warrants for Gross Proceeds of Over $2.3 Million (newsfilecorp.com)

255